ERBB2 and breast carcinoma: For gene TOP2A, it has been proposed that the HER2 amplification in HER2 breast cancers may be a direct result of the frequent co-amplification of TOP2A [64–66], and there is a high correlation between the high expressions of TOP2A and the oncogene HER2 [67, 68].